Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


How IDEXX’s Diagnostics-Focused CEO Transition At IDEXX Laboratories (IDXX) Has Changed Its Investment Story

2026-01-13
On January 13, 2026, IDEXX Laboratories announced that Michael (Mike) Erickson, PhD, will become President and CEO on May 12, 2026, as current President and CEO Jonathan (Jay) Mazelsky moves to Executive Chair before retiring after the May 2027 shareholder meeting. Erickson’s elevation from leading IDEXX’s Global Point of Care Diagnostics and Telemedicine businesses to the top role signals continuity in focusing on advanced diagnostic solutions and healthcare technology innovation. We’ll now...

Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point

2026-01-13
Dow Jones retail giant Amazon is approaching a fresh buy point, as the stock market holds near record highs.

IDEXX Announces CEO Succession

2026-01-13
WESTBROOK, Maine, January 13, 2026--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026, at which time Jonathan (Jay) Mazelsky, President and CEO, will transition to the role of Executive Chair of IDEXX’s Board of Directors (the "Board"). Mr. Mazelsky has announced his intention to retire from the Company immediately following the Comp

IDEXX Laboratories (IDXX): From a Detractor to a Revivor

2026-01-13
Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here. The fund focuses on investing in equities globally. The T Class Accumulation shares where the firm invested returned 0.8% in 2025, compared to 12.8% for the […]

RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?

2026-01-13
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Is It Too Late To Consider Buying IDEXX Laboratories (IDXX) After A 71% One Year Rally

2026-01-10
If you are wondering whether IDEXX Laboratories is still fairly priced after a strong run, this article walks through what the current share price could mean for long term investors. The stock last closed at US$713.35, with returns of 6.5% over the past week, 0.8% over the past month, 6.5% year to date, 70.6% over 1 year, 48.9% over 3 years, and 45.7% over 5 years. Recent coverage around IDEXX has focused on how its position in veterinary diagnostics and related services fits into long term...

IBD Stock Of The Day: Pet-Health Firm Idexx Laboratories Looks To Build On 2025 Rally

2026-01-09
Idexx stock is starting the year strong as Wall Street remains bullish the animal diagnostics company.

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

2026-01-09
WESTBROOK, Maine, January 09, 2026--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More

2026-01-08
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.One of the key drivers of the veterinary infectious disease diagnostics market is the rising prevalence of zoonotic diseases. Zoonotic diseases those transmitted from animals to humans pose sig

Dow Jones Futures Fall; Lockheed, Defense Giants Bounce On $1.5 Trillion Trump 'Dream Military'

2026-01-08
Futures fell. Lockheed Martin and other defense giants jumped on Trump's proposed $1.5 trillion "Dream Military" budget.